Literature DB >> 21039918

An intrapatient comparison of quality of life in psoriasis in childhood and adulthood.

M E A de Jager1, E M G J de Jong, P C M van de Kerkhof, A W M Evers, M M B Seyger.   

Abstract

BACKGROUND: Chronic diseases can have a great influence on health-related quality of life. Nevertheless, only little research has been carried out on childhood psoriasis. The perception of quality of life by adults with psoriasis of their childhood psoriasis has never been investigated.
OBJECTIVES: The aims of this study were to (i) investigate retrospectively the influence of psoriasis as experienced in childhood as compared with the current quality of life in adulthood; (ii) assess retrospectively the impact of childhood psoriasis on daily life; and (iii) compare the current quality of life in patients with childhood onset psoriasis (COP) and adult onset psoriasis (AOP).
METHODS: A survey was performed among all members of the Dutch Psoriasis Society. Validated questionnaires on quality of life, impact on daily life and clinical severity were used.
RESULTS: Questionnaires of 1762 patients were suitable for analysis. Adults with an onset of psoriasis before the age of 18 years retrospectively rate their quality of life during childhood much less as compared with their current quality of life (intrapatient comparison). Influence of psoriasis in childhood particularly had a high degree of limitations on recreational and social activities in 15-30% of patients. Quality of life in adulthood is not determined by age of onset of psoriasis.
CONCLUSIONS: In childhood, the quality of life is greatly influenced by psoriasis. The social development domain, which is one of the developmental milestones in a child, is particularly impaired. The current quality of life of patients with COP is equal to that of patients with AOP.
© 2010 The Authors. Journal of the European Academy of Dermatology and Venereology © 2010 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2010        PMID: 21039918     DOI: 10.1111/j.1468-3083.2010.03872.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  6 in total

Review 1.  Adolescent Scalp Psoriasis: Update on Topical Combination Therapy.

Authors:  Emily Osier; Barbara Gomez; Lawrence F Eichenfield
Journal:  J Clin Aesthet Dermatol       Date:  2015-07

2.  Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12-17 years of age.

Authors:  M Gooderham; J-M Debarre; J Keddy-Grant; Z Xu; M Kurvits; M Goodfield
Journal:  Br J Dermatol       Date:  2014-10-22       Impact factor: 9.302

3.  Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study.

Authors:  D Thaçi; K Papp; D Marcoux; L Weibel; A Pinter; P-D Ghislain; I Landells; P H Hoeger; K Unnebrink; M M B Seyger; D A Williams; S Rubant; S Philipp
Journal:  Br J Dermatol       Date:  2019-07-25       Impact factor: 9.302

4.  Recommendations for Management of Childhood Psoriasis.

Authors:  Bhumesh Kumar Katakam; Malathi Munisamy; T Narayana Rao; Minu Jose Chiramel; Maitreyee Panda; Sandeep Gupta; Ranugha Pss; K A Seetharam
Journal:  Indian Dermatol Online J       Date:  2021-11-25

5.  Improved patient satisfaction using ingenol mebutate gel 0.015% for the treatment of facial actinic keratoses: a prospective pilot study.

Authors:  Joanna Emilio; Michelle Schwartz; Eleanor Feldman; Amy Kalowitz Bieber; Amanda Bienenfeld; Min-Kyung Jung; Daniel M Siegel; Orit Markowitz
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-04-20

6.  Methylome profiling of young adults with depression supports a link with immune response and psoriasis.

Authors:  Coral R Lapsley; Rachelle Irwin; Margaret McLafferty; Sara Jayne Thursby; Siobhan M O'Neill; Anthony J Bjourson; Colum P Walsh; Elaine K Murray
Journal:  Clin Epigenetics       Date:  2020-06-15       Impact factor: 6.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.